{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:46:30Z","timestamp":1793357190178,"version":"4.5.0"},"reference-count":196,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1038\/s41581-018-0057-8","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:20:40Z","timestamp":1536682840000},"page":"636-655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["HLA and kidney disease: from associations to mechanisms"],"prefix":"10.1038","volume":"14","author":[{"given":"Kate J.","family":"Robson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Holdsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Rossjohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2713-2391","authenticated-orcid":false,"given":"A. Richard","family":"Kitching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"key":"57_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","volume":"33","author":"GS Cooper","year":"2009","unstructured":"Cooper, G. S., Bynum, M. L. & Somers, E. C. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J. Autoimmun. 33, 197\u2013207 (2009).","journal-title":"J. Autoimmun."},{"key":"57_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","volume":"130","author":"CC Goodnow","year":"2007","unstructured":"Goodnow, C. C. Multistep pathogenesis of autoimmune disease. Cell 130, 25\u201335 (2007).","journal-title":"Cell"},{"key":"57_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri.2017.143","volume":"18","author":"CA Dendrou","year":"2018","unstructured":"Dendrou, C. A., Petersen, J., Rossjohn, J. & Fugger, L. HLA variation and disease. Nat. Rev. Immunol. 18, 325\u2013339 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"57_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrg.2017.12","volume":"18","author":"JY Yang","year":"2017","unstructured":"Yang, J. Y. & Sarwal, M. M. Transplant genetics and genomics. Nat. Rev. Genet. 18, 309\u2013326 (2017).","journal-title":"Nat. Rev. Genet."},{"key":"57_CR5","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1172\/JCI90595","volume":"127","author":"S DeWolf","year":"2017","unstructured":"DeWolf, S. & Sykes, M. Alloimmune T cells in transplantation. J. Clin. Invest. 127, 2473\u20132481 (2017).","journal-title":"J. Clin. Invest."},{"key":"57_CR6","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1097\/TP.0000000000001830","volume":"101","author":"EP Kransdorf","year":"2017","unstructured":"Kransdorf, E. P., Pando, M. J., Gragert, L. & Kaplan, B. HLA population genetics in solid organ transplantation. Transplantation 101, 1971\u20131976 (2017).","journal-title":"Transplantation"},{"key":"57_CR7","first-page":"179","volume":"3","author":"DD Chaplin","year":"1988","unstructured":"Chaplin, D. D. & Kemp, M. E. The major histocompatibility complex and autoimmunity. Year Immunol. 3, 179\u2013198 (1988).","journal-title":"Year Immunol."},{"key":"57_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01398.x","volume":"167","author":"P Price","year":"1999","unstructured":"Price, P. et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167, 257\u2013274 (1999).","journal-title":"Immunol. Rev."},{"key":"57_CR9","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1084\/jem.184.3.923","volume":"184","author":"C Kurts","year":"1996","unstructured":"Kurts, C. et al. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184, 923\u2013930 (1996).","journal-title":"J. Exp. Med."},{"key":"57_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev-immunol-032414-112334","volume":"33","author":"J Rossjohn","year":"2015","unstructured":"Rossjohn, J. et al. T cell antigen receptor recognition of antigen-presenting molecules. Annu. Rev. Immunol. 33, 169\u2013200 (2015).","journal-title":"Ann. Rev. Immunol."},{"key":"57_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature22329","volume":"545","author":"JD Ooi","year":"2017","unstructured":"Ooi, J. D. et al. Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells. Nature 545, 243\u2013247 (2017).","journal-title":"Nature"},{"key":"57_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/334395a0","volume":"334","author":"MM Davis","year":"1988","unstructured":"Davis, M. M. & Bjorkman, P. J. T cell antigen receptor genes and T cell recognition. Nature 334, 395\u2013402 (1988).","journal-title":"Nature"},{"key":"57_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/bmj.2.5654.424","volume":"2","author":"R Patel","year":"1969","unstructured":"Patel, R., Mickey, M. R. & Terasaki, P. I. Leucocyte antigens and disease. I. Association of HLA2 and chronic glomerulonephritis. BMJ 2, 424\u2013426 (1969).","journal-title":"BMJ"},{"key":"57_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1399-0039.2010.01466.x","volume":"75","author":"SG Marsh","year":"2010","unstructured":"Marsh, S. G. et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens 75, 291\u2013455 (2010).","journal-title":"Tissue Antigens"},{"key":"57_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneph.2016.18","volume":"12","author":"SR Holdsworth","year":"2016","unstructured":"Holdsworth, S. R., Gan, P. Y. & Kitching, A. R. Biologics for the treatment of autoimmune renal diseases. Nat.\u00a0Rev. Nephrol. 12, 217\u2013231 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"57_CR16","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1046\/j.1523-1755.1999.00720.x","volume":"56","author":"RG Phelps","year":"1999","unstructured":"Phelps, R. G. & Rees, A. J. The HLA complex in Goodpasture\u2019s disease: a model for analyzing susceptibility to autoimmunity. Kidney Int. 56, 1638\u20131653 (1999).","journal-title":"Kidney Int."},{"key":"57_CR17","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1093\/ndt\/gfn179","volume":"23","author":"W Kitagawa","year":"2008","unstructured":"Kitagawa, W. et al. The HLA-DRB1 1501 allele is prevalent among Japanese patients with anti-glomerular basement membrane antibody-mediated disease. Nephrol. Dial. Transplant. 23, 3126\u20133129 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"57_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.clim.2009.07.005","volume":"133","author":"R Yang","year":"2009","unstructured":"Yang, R., Cui, Z., Zhao, J. & Zhao, M. H. The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease. Clin. Immunol. 133, 245\u2013250 (2009).","journal-title":"Clin. Immunol."},{"key":"57_CR19","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1681\/ASN.2016020114","volume":"28","author":"Z Cui","year":"2017","unstructured":"Cui, Z. et al. MHC class II risk alleles and amino acid residues in idiopathic membranous nephropathy. J.\u00a0Am. Soc. Nephrol. 28, 1651\u20131664 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR20","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1681\/ASN.2016060644","volume":"28","author":"WB Le","year":"2017","unstructured":"Le, W. B. et al. HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-related membranous nephropathy. J. Am. Soc. Nephrol. 28, 1642\u20131650 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/ndt\/gfw001","volume":"32","author":"P Sekula","year":"2017","unstructured":"Sekula, P. et al. Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies. Nephrol. Dial. Transplant. 32, 325\u2013332 (2017).","journal-title":"Nephrol. Dial. Transplant."},{"key":"57_CR22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1056\/NEJMoa1009742","volume":"364","author":"HC Stanescu","year":"2011","unstructured":"Stanescu, H. C. et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N.\u00a0Eng. J. Med. 364, 616\u2013626 (2011).","journal-title":"N. Eng. J. Med."},{"key":"57_CR23","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1681\/ASN.2009030337","volume":"20","author":"SA Summers","year":"2009","unstructured":"Summers, S. A. et al. TH1 and TH17 cells induce proliferative glomerulonephritis. J. Am. Soc. Nephrol. 20, 2518\u20132524 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03181-4","volume":"9","author":"CLV Westhorpe","year":"2018","unstructured":"Westhorpe, C. L. V. et al. Effector CD4(+) T cells recognize intravascular antigen presented by patrolling monocytes. Nat. Commun. 9, 747 (2018).","journal-title":"Nat. Commun."},{"key":"57_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1681\/ASN.2015121356","volume":"28","author":"J Chang","year":"2017","unstructured":"Chang, J. et al. CD8+ T cells effect glomerular injury in\u00a0experimental anti-myeloperoxidase GN. J. Am. Soc. Nephrol. 28, 47\u201355 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/01.ASN.0000114553.36258.91","volume":"15","author":"T Kruger","year":"2004","unstructured":"Kruger, T. et al. Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J. Am. Soc. Nephrol. 15, 613\u2013621 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/sj.ki.5001567","volume":"70","author":"TJ Soos","year":"2006","unstructured":"Soos, T. J. et al. CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int. 70, 591\u2013596 (2006).","journal-title":"Kidney Int."},{"key":"57_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/art.23186","volume":"58","author":"M Tucci","year":"2008","unstructured":"Tucci, M. et al. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum. 58, 251\u2013262 (2008).","journal-title":"Arthritis Rheum."},{"key":"57_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ki.1989.16","volume":"35","author":"CA Muller","year":"1989","unstructured":"Muller, C. A., Markovic-Lipkovski, J., Risler, T., Bohle, A. & Muller, G. A. Expression of HLA-DQ, -DR, and -DP antigens in normal kidney and glomerulonephritis. Kidney Int. 35, 116\u2013124 (1989).","journal-title":"Kidney Int."},{"key":"57_CR30","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1681\/ASN.2012020133","volume":"24","author":"A Goldwich","year":"2013","unstructured":"Goldwich, A. et al. Podocytes are nonhematopoietic professional antigen-presenting cells. J. Am. Soc. Nephrol. 24, 906\u2013916 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ki.2008.191","volume":"74","author":"OM Steinmetz","year":"2008","unstructured":"Steinmetz, O. M. et al. Analysis and classification of B cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int. 74, 448\u2013457 (2008).","journal-title":"Kidney Int."},{"key":"57_CR32","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.4049\/jimmunol.1500792","volume":"195","author":"JR Giles","year":"2015","unstructured":"Giles, J. R., Kashgarian, M., Koni, P. A. & Shlomchik, M. J. B. Cell-specific MHC class II deletion reveals multiple nonredundant roles for B cell antigen presentation in murine lupus. J. Immunol. 195, 2571\u20132579 (2015).","journal-title":"J. Immunol."},{"key":"57_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0140-6736(84)90297-6","volume":"2","author":"BM Hall","year":"1984","unstructured":"Hall, B. M. et al. Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet 2, 247\u2013251 (1984).","journal-title":"Lancet"},{"key":"57_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ki.1990.14","volume":"37","author":"E Alexopoulos","year":"1990","unstructured":"Alexopoulos, E., Seron, D., Hartley, R. B. & Cameron, J. S. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int. 37, 100\u2013109 (1990).","journal-title":"Kidney Int."},{"key":"57_CR35","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/ndt\/gfq677","volume":"26","author":"R Wilkinson","year":"2011","unstructured":"Wilkinson, R., Wang, X., Roper, K. E. & Healy, H. Activated human renal tubular cells inhibit autologous immune responses. Nephrol. Dial. Transplant. 26, 1483\u20131492 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"57_CR36","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1126\/science.3368786","volume":"240","author":"JA Todd","year":"1988","unstructured":"Todd, J. A. et al. A molecular basis for MHC class II \u2014 associated autoimmunity. Science 240, 1003\u20131009 (1988).","journal-title":"Science"},{"key":"57_CR37","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1084\/jem.20131241","volume":"210","author":"SW Scally","year":"2013","unstructured":"Scally, S. W. et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J. Exp. Med. 210, 2569\u20132582 (2013).","journal-title":"J. Exp. Med."},{"key":"57_CR38","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","volume":"387","author":"F Pociot","year":"2016","unstructured":"Pociot, F. & Lernmark, A. Genetic risk factors for type\u00a01 diabetes. Lancet 387, 2331\u20132339 (2016).","journal-title":"Lancet"},{"key":"57_CR39","unstructured":"Raj, P. et al. Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity. eLife 5, e12089 (2016)."},{"key":"57_CR40","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.aad2791","volume":"351","author":"T Delong","year":"2016","unstructured":"Delong, T. et al. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 351, 711\u2013714 (2016).","journal-title":"Science"},{"key":"57_CR41","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.immuni.2009.01.009","volume":"30","author":"M Harkiolaki","year":"2009","unstructured":"Harkiolaki, M. et al. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 30, 348\u2013357 (2009).","journal-title":"Immunity"},{"key":"57_CR42","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMra022296","volume":"348","author":"BG Hudson","year":"2003","unstructured":"Hudson, B. G., Tryggvason, K., Sundaramoorthy, M. & Neilson, E. G. Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen. N. Engl. J. Med. 348, 2543\u20132556 (2003).","journal-title":"N. Engl. J. Med."},{"key":"57_CR43","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/eji.200324354","volume":"34","author":"C Rich","year":"2004","unstructured":"Rich, C. et al. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice. Eur. J. Immunol. 34, 1251\u20131261 (2004).","journal-title":"Eur. J. Immunol."},{"key":"57_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1681\/ASN.2012070705","volume":"24","author":"JD Ooi","year":"2013","unstructured":"Ooi, J. D. et al. The HLA-DRB1*15:01-restricted Goodpasture\u2019s T cell epitope induces GN. J. Am. Soc. Nephrol. 24, 419\u2013431 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR45","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1097\/01.ASN.0000091588.80007.0E","volume":"14","author":"LS Cairns","year":"2003","unstructured":"Cairns, L. S. et al. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture\u2019s disease. J.\u00a0Am. Soc. Nephrol. 14, 2801\u20132812 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR46","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1073\/pnas.1211391110","volume":"110","author":"S Tsai","year":"2013","unstructured":"Tsai, S. et al. Antidiabetogenic MHC class II promotes the differentiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells. Proc. Natl Acad. Sci. USA 110, 3471\u20133476 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"57_CR47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nrrheum.2015.59","volume":"11","author":"F Koning","year":"2015","unstructured":"Koning, F., Thomas, R., Rossjohn, J. & Toes, R. E. Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens. Nat. Rev. Rheumatol. 11, 450\u2013461 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"57_CR48","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nature05133","volume":"443","author":"JW Gregersen","year":"2006","unstructured":"Gregersen, J. W. et al. Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature 443, 574\u2013577 (2006).","journal-title":"Nature"},{"key":"57_CR49","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nature11147","volume":"486","author":"PT Illing","year":"2012","unstructured":"Illing, P. T. et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486, 554\u2013558 (2012).","journal-title":"Nature"},{"key":"57_CR50","doi-asserted-by":"publisher","first-page":"11267","DOI":"10.1074\/jbc.274.16.11267","volume":"274","author":"KO Netzer","year":"1999","unstructured":"Netzer, K. O. et al. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17\u201331 and 127\u2013141 of the NC1 domain. J. Biol. Chem. 274, 11267\u201311274 (1999).","journal-title":"J. Biol. Chem."},{"key":"57_CR51","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0140-6736(78)90252-0","volume":"1","author":"AJ Rees","year":"1978","unstructured":"Rees, A. J., Peters, D. K., Compston, D. A. & Batchelor, J. R. Strong association between HLA-DRW2 and antibody-mediated Goodpasture\u2019s syndrome. Lancet 1, 966\u2013968 (1978).","journal-title":"Lancet"},{"key":"57_CR52","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ki.1997.27","volume":"51","author":"M Fisher","year":"1997","unstructured":"Fisher, M., Pusey, C. D., Vaughan, R. W. & Rees, A. J. Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes. Kidney Int. 51, 222\u2013229 (1997).","journal-title":"Kidney Int."},{"key":"57_CR53","first-page":"249","volume":"9","author":"H Dunckley","year":"1991","unstructured":"Dunckley, H. et al. HLA-DR and -DQ genotyping in anti-GBM disease. Dis. Markers 9, 249\u2013256 (1991).","journal-title":"Dis. Markers"},{"key":"57_CR54","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/ki.1993.245","volume":"44","author":"B Huey","year":"1993","unstructured":"Huey, B. et al. Associations of HLA-DR and HLA-DQ types with anti-GBM nephritis by sequence-specific oligonucleotide probe hybridization. Kidney Int. 44, 307\u2013312 (1993).","journal-title":"Kidney Int."},{"key":"57_CR55","first-page":"658","volume":"3","author":"B Mercier","year":"1992","unstructured":"Mercier, B. et al. HLA class II typing of Goodpasture\u2019s syndrome affected patients. J. Am. Soc. Nephrol. 3, 658 (1992).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2369-12-21","volume":"12","author":"H Luo","year":"2011","unstructured":"Luo, H. et al. The association of HLA-DQB1, -DQA1 and -DPB1 alleles with anti- glomerular basement membrane (GBM) disease in Chinese patients. BMC\u00a0Nephrol. 12, 21 (2011).","journal-title":"BMC Nephrol."},{"key":"57_CR57","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/imm.12736","volume":"151","author":"LJ Xie","year":"2017","unstructured":"Xie, L. J. et al. The susceptible HLA class II alleles and their presenting epitope(s) in Goodpasture\u2019s disease. Immunology 151, 395\u2013404 (2017).","journal-title":"Immunology"},{"key":"57_CR58","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.kint.2017.03.014","volume":"92","author":"SP McAdoo","year":"2017","unstructured":"McAdoo, S. P. et al. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int. 92, 693\u2013702 (2017).","journal-title":"Kidney Int."},{"key":"57_CR59","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/ki.1990.72","volume":"37","author":"DR Jayne","year":"1990","unstructured":"Jayne, D. R., Marshall, P. D., Jones, S. J. & Lockwood, C. M. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int. 37, 965\u2013970 (1990).","journal-title":"Kidney Int."},{"key":"57_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck, L. H. Jr et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 361, 11\u201321 (2009).","journal-title":"N. Engl. J. Med."},{"key":"57_CR61","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.2215\/CJN.07210810","volume":"6","author":"JM Hofstra","year":"2011","unstructured":"Hofstra, J. M., Beck, L. H. Jr, Beck, D. M., Wetzels, J. F. & Salant, D. J. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol. 6, 1286\u20131291 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"57_CR62","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","volume":"371","author":"NM Tomas","year":"2014","unstructured":"Tomas, N. M. et al. Thrombospondin type1 domain-containing 7A in idiopathic membranous nephropathy. N. Engl. J. Med. 371, 2277\u20132287 (2014).","journal-title":"N. Engl. J. Med."},{"key":"57_CR63","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S0140-6736(79)92118-4","volume":"2","author":"PT Klouda","year":"1979","unstructured":"Klouda, P. T. et al. Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet 2, 770\u2013771 (1979).","journal-title":"Lancet"},{"key":"57_CR64","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1399-0039.1982.tb00350.x","volume":"20","author":"JC Le Petit","year":"1982","unstructured":"Le Petit, J. C., Laurent, B. & Berthoux, F. C. HLA-DR3 and idiopathic membranous nephritis (IMN) association. Tissue Antigens 20, 227\u2013228 (1982).","journal-title":"Tissue Antigens"},{"key":"57_CR65","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1399-0039.1981.tb00708.x","volume":"17","author":"GA Muller","year":"1981","unstructured":"Muller, G. A. et al. Strong association of idiopathic membranous nephropathy (IMN) with HLA-DR 3 and MT-2 without involvement of HLA-B 18 and no association to BfF1. Tissue Antigens 17, 332\u2013337 (1981).","journal-title":"Tissue Antigens"},{"key":"57_CR66","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1399-0039.1989.tb01741.x","volume":"34","author":"RW Vaughan","year":"1989","unstructured":"Vaughan, R. W., Demaine, A. G. & Welsh, K. I. A. DQA1 allele is strongly associated with idiopathic membranous nephropathy. Tissue Antigens 34, 261\u2013269 (1989).","journal-title":"Tissue Antigens"},{"key":"57_CR67","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1681\/ASN.2012080771","volume":"24","author":"J Lv","year":"2013","unstructured":"Lv, J. et al. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy. J. Am. Soc. Nephrol. 24, 1323\u20131329 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR68","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2215\/CJN.05310513","volume":"9","author":"G Bullich","year":"2014","unstructured":"Bullich, G. et al. HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol. 9, 335\u2013343 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"57_CR69","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/gene.2014.50","volume":"15","author":"M Saeed","year":"2014","unstructured":"Saeed, M., Beggs, M. L., Walker, P. D. & Larsen, C. P. PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes. Genes Immun. 15, 556\u2013561 (2014).","journal-title":"Genes Immun."},{"key":"57_CR70","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/ndt\/gfv399","volume":"31","author":"R Ramachandran","year":"2016","unstructured":"Ramachandran, R. et al. PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians. Nephrol. Dial. Transplant. 31, 1486\u20131493 (2016).","journal-title":"Nephrol. Dial. Transplant."},{"key":"57_CR71","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000183162","volume":"36","author":"S Tomura","year":"1984","unstructured":"Tomura, S. et al. Strong association of idiopathic membranous nephropathy with HLA-DR2 and MT1 in Japanese. Nephron 36, 242\u2013245 (1984).","journal-title":"Nephron"},{"key":"57_CR72","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/ki.1984.116","volume":"25","author":"Y Hiki","year":"1984","unstructured":"Hiki, Y., Kobayashi, Y., Itoh, I. & Kashiwagi, N. Strong association of HLA-DR2 and MT1 with idiopathic membranous nephropathy in Japan. Kidney Int. 25, 953\u2013957 (1984).","journal-title":"Kidney Int."},{"key":"57_CR73","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ki.1992.24","volume":"41","author":"S Ogahara","year":"1992","unstructured":"Ogahara, S., Naito, S., Abe, K., Michinaga, I. & Arakawa, K. Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis. Kidney Int. 41, 175\u2013182 (1992).","journal-title":"Kidney Int."},{"key":"57_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette, J. C. et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 65, 1\u201311 (2013).","journal-title":"Arthritis Rheum."},{"key":"57_CR75","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1681\/ASN.2014090903","volume":"26","author":"M Hilhorst","year":"2015","unstructured":"Hilhorst, M., van Paassen, P. & Tervaert, J. W. Proteinase 3-ANCA vasculitis versus myeloperoxidase-ANCA vasculitis. J. Am. Soc. Nephrol. 26, 2314\u20132327 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR76","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"Lyons, P. A. et al. Genetically distinct subsets within ANCA-associated vasculitis. N. Eng. J. Med. 367, 214\u2013223 (2012).","journal-title":"N. Eng. J. Med."},{"key":"57_CR77","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1365-2273.1991.tb01037.x","volume":"16","author":"GE Murty","year":"1991","unstructured":"Murty, G. E., Mains, B. T., Middleton, D., Maxwell, A. P. & Savage, D. A. HLA antigen frequencies and Wegener\u2019s granulomatosis. Clin. Otolaryngol. Allied Sci. 16, 448\u2013451 (1991).","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"57_CR78","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/ard.51.2.246","volume":"51","author":"SS Papiha","year":"1992","unstructured":"Papiha, S. S., Murty, G. E., Ad\u2019Hia, A., Mains, B. T. & Venning, M. Association of Wegener\u2019s granulomatosis with HLA antigens and other genetic markers. Ann. Rheum. Dis. 51, 246\u2013248 (1992).","journal-title":"Ann. Rheum. Dis."},{"key":"57_CR79","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/ard.2007.077693","volume":"67","author":"M Heckmann","year":"2008","unstructured":"Heckmann, M. et al. The Wegener\u2019s granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping. Ann. Rheum. Dis. 67, 972\u2013979 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"57_CR80","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/art.39620","volume":"68","author":"M Hilhorst","year":"2016","unstructured":"Hilhorst, M. et al. HLA-DPB1 as a risk factor for relapse in antineutrophil cytoplasmic antibody-associated vasculitis: a cohort study. Arthritis Rheumatol. 68, 1721\u20131730 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"57_CR81","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00439-004-1092-z","volume":"114","author":"P Jagiello","year":"2004","unstructured":"Jagiello, P. et al. New genomic region for Wegener\u2019s granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum. Genet. 114, 468\u2013477 (2004).","journal-title":"Hum. Genet."},{"key":"57_CR82","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1002\/art.38036","volume":"65","author":"G Xie","year":"2013","unstructured":"Xie, G. et al. Association of granulomatosis with polyangiitis (Wegener\u2019s) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum. 65, 2457\u20132468 (2013).","journal-title":"Arthritis Rheum."},{"key":"57_CR83","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/art.40034","volume":"69","author":"PA Merkel","year":"2017","unstructured":"Merkel, P. A. et al. Identification of functional and expression polymorphisms associated with risk for antineutrophil cytoplasmic autoantibody-associated vasculitis. Arthritis Rheumatol. 69, 1054\u20131066 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"57_CR84","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/1756-185X.12561","volume":"20","author":"Z Wu","year":"2017","unstructured":"Wu, Z. et al. HLA-DPB1 variant rs3117242 is associated with anti-neutrophil cytoplasmic antibody-associated vasculitides in a Han Chinese population. Int. J. Rheum. Dis. 20, 1009\u20131015 (2017).","journal-title":"Int. J. Rheum. Dis."},{"key":"57_CR85","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1681\/ASN.2010101058","volume":"22","author":"Y Cao","year":"2011","unstructured":"Cao, Y. et al. DRB1 15 allele is a risk factor for PR3ANCA disease in African Americans. J. Am. Soc. Nephrol. 22, 1161\u20131167 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154393","volume":"11","author":"A Kawasaki","year":"2016","unstructured":"Kawasaki, A. et al. Protective role of HLA-DRB1 13:02 against microscopic polyangiitis and MPO-ANCA-positive vasculitides in a Japanese population: a case-control study. PLOS ONE 11, e0154393 (2016).","journal-title":"PLOS ONE"},{"key":"57_CR87","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s10157-012-0691-6","volume":"17","author":"N Tsuchiya","year":"2013","unstructured":"Tsuchiya, N. Genetics of ANCA-associated vasculitis in\u00a0Japan: a role for HLA-DRB1 09:01 haplotype. Clin. Exp. Nephrol. 17, 628\u2013630 (2013).","journal-title":"Clin. Exp. Nephrol."},{"key":"57_CR88","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/sj.gene.6364262","volume":"7","author":"N Tsuchiya","year":"2006","unstructured":"Tsuchiya, N., Kobayashi, S., Hashimoto, H., Ozaki, S. & Tokunaga, K. Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese. Genes Immun. 7, 81\u201384 (2006).","journal-title":"Genes Immun."},{"key":"57_CR89","first-page":"1534","volume":"30","author":"N Tsuchiya","year":"2003","unstructured":"Tsuchiya, N. et al. Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis. J.\u00a0Rheumatol. 30, 1534\u20131540 (2003).","journal-title":"J. Rheumatol."},{"key":"57_CR90","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.humimm.2011.02.017","volume":"72","author":"H Luo","year":"2011","unstructured":"Luo, H., Chen, M., Yang, R., Xu, P. C. & Zhao, M. H. The association of HLA-DRB1 alleles with antineutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese patients. Hum. Immunol. 72, 422\u2013425 (2011).","journal-title":"Hum. Immunol."},{"key":"57_CR91","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1002\/art.22834","volume":"56","author":"A Vaglio","year":"2007","unstructured":"Vaglio, A. et al. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum. 56, 3159\u20133166 (2007).","journal-title":"Arthritis Rheum."},{"key":"57_CR92","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/art.23209","volume":"58","author":"S Wieczorek","year":"2008","unstructured":"Wieczorek, S., Hellmich, B., Gross, W. L. & Epplen, J. T. Associations of Churg-Strauss syndrome with the HLA-DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody-associated vasculitides: comment on the article by Vaglio et al. Arthritis Rheum. 58, 329\u2013330 (2008).","journal-title":"Arthritis Rheum."},{"key":"57_CR93","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1365-2249.1995.tb03724.x","volume":"100","author":"AC Allen","year":"1995","unstructured":"Allen, A. C., Harper, S. J. & Feehally, J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin. Exp. Immunol. 100, 470\u2013474 (1995).","journal-title":"Clin. Exp. Immunol."},{"key":"57_CR94","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12016-010-8232-0","volume":"41","author":"HH Yu","year":"2011","unstructured":"Yu, H. H. et al. Genetics and immunopathogenesis of IgA nephropathy. Clin. Rev. Allergy Immunol. 41, 198\u2013213 (2011).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"57_CR95","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000348652","volume":"181","author":"J Xie","year":"2013","unstructured":"Xie, J., Shapiro, S. & Gharavi, A. Genetic studies of IgA nephropathy: what have we learned from genome-wide association studies. Contribut. Nephrol. 181, 52\u201364 (2013).","journal-title":"Contribut. Nephrol."},{"key":"57_CR96","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000381738","volume":"1","author":"J Feehally","year":"2015","unstructured":"Feehally, J. & Barratt, J. The genetics of IgA nephropathy: an overview from western countries. Kidney Dis. 1, 33\u201341 (2015).","journal-title":"Kidney Dis."},{"key":"57_CR97","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0272-6386(12)80996-6","volume":"23","author":"BI Freedman","year":"1994","unstructured":"Freedman, B. I., Spray, B. J. & Heise, E. R. HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis. Am. J. Kidney Dis. 23, 352\u2013357 (1994).","journal-title":"Am. J. Kidney Dis."},{"key":"57_CR98","first-page":"1034","volume":"298","author":"FC Berthoux","year":"1978","unstructured":"Berthoux, F. C. et al. HLA-Bw35 and mesangial IgA glomerulonephritis. N. Eng. J. Med. 298, 1034\u20131035 (1978).","journal-title":"N. Eng. J. Med."},{"key":"57_CR99","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000185867","volume":"54","author":"Y Hiki","year":"1990","unstructured":"Hiki, Y., Kobayashi, Y., Ookubo, M. & Kashiwagi, N. The role of HLA-DR4 in the long-term prognosis of IgA nephropathy. Nephron 54, 264\u2013265 (1990).","journal-title":"Nephron"},{"key":"57_CR100","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000182849","volume":"32","author":"Y Hiki","year":"1982","unstructured":"Hiki, Y., Kobayashi, Y., Tateno, S., Sada, M. & Kashiwagi, N. Strong association of HLA-DR4 with benign IgA nephropathy. Nephron 32, 222\u2013226 (1982).","journal-title":"Nephron"},{"key":"57_CR101","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0090-1229(82)90181-7","volume":"25","author":"M Kasahara","year":"1982","unstructured":"Kasahara, M. et al. Role of HLA in IgA nephropathy. Clin. Immunol. Immunopathol. 25, 189\u2013195 (1982).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"57_CR102","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ki.1982.185","volume":"22","author":"H Kashiwabara","year":"1982","unstructured":"Kashiwabara, H., Shishido, H., Tomura, S., Tuchida, H. & Miyajima, T. Strong association between IgA nephropathy and HLA-DR4 antigen. Kidney Int. 22, 377\u2013382 (1982).","journal-title":"Kidney Int."},{"key":"57_CR103","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000184089","volume":"45","author":"S Naito","year":"1987","unstructured":"Naito, S., Kohara, M. & Arakawa, K. Association of class II antigens of HLA with primary glomerulopathies. Nephron 45, 111\u2013114 (1987).","journal-title":"Nephron"},{"key":"57_CR104","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000187434","volume":"65","author":"J Abe","year":"1993","unstructured":"Abe, J., Kohsaka, T., Tanaka, M. & Kobayashi, N. Genetic study on HLA class II and class III region in the disease associated with IgA nephropathy. Nephron 65, 17\u201322 (1993).","journal-title":"Nephron"},{"key":"57_CR105","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000186389","volume":"58","author":"Y Hiki","year":"1991","unstructured":"Hiki, Y., Kobayashi, Y., Ookubo, M., Obata, F. & Kashiwagi, N. Association of HLA-DQw4 with IgA nephropathy in the Japanese population. Nephron 58, 109\u2013111 (1991).","journal-title":"Nephron"},{"key":"57_CR106","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1681\/ASN.2010010076","volume":"21","author":"J Feehally","year":"2010","unstructured":"Feehally, J. et al. HLA has strongest association with IgA nephropathy in genome-wide analysis. J. Am. Soc. Nephrol. 21, 1791\u20131797 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR107","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng.787","volume":"43","author":"AG Gharavi","year":"2011","unstructured":"Gharavi, A. G. et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat.\u00a0Genet. 43, 321\u2013327 (2011).","journal-title":"Nat. Genet."},{"key":"57_CR108","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3118","volume":"46","author":"K Kiryluk","year":"2014","unstructured":"Kiryluk, K. et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat. Genet. 46, 1187\u20131196 (2014).","journal-title":"Nat. Genet."},{"key":"57_CR109","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ng.1047","volume":"44","author":"XQ Yu","year":"2012","unstructured":"Yu, X. Q. et al. A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat. Genet. 44, 178\u2013182 (2012).","journal-title":"Nat. Genet."},{"key":"57_CR110","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1399-0039.1995.tb02447.x","volume":"45","author":"O Raguenes","year":"1995","unstructured":"Raguenes, O., Mercier, B., Cledes, J., Whebe, B. & Ferec, C. HLA class II typing and idiopathic IgA nephropathy (IgAN): DQB1*0301, a possible marker\u00a0of unfavorable outcome. Tissue Antigens 45, 246\u2013249 (1995).","journal-title":"Tissue Antigens"},{"key":"57_CR111","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10067-007-0640-z","volume":"27","author":"H Peru","year":"2008","unstructured":"Peru, H. et al. HLA class 1 associations in Henoch Schonlein purpura: increased and decreased frequencies. Clin. Rheumatol. 27, 5\u201310 (2008).","journal-title":"Clin. Rheumatol."},{"key":"57_CR112","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4238\/2012.February.3.2","volume":"11","author":"SM Ren","year":"2012","unstructured":"Ren, S. M. et al. Association between HLAA and B polymorphisms and susceptibility to Henoch-Schonlein purpura in Han and Mongolian children from inner Mongolia. Gen. Mol. Res. 11, 221\u2013228 (2012).","journal-title":"Gen. Mol. Res."},{"key":"57_CR113","first-page":"1266","volume":"28","author":"MM Amoli","year":"2001","unstructured":"Amoli, M. M. et al. HLA-DRB1 01 association with Henoch-Schonlein purpura in patients from northwest Spain. J. Rheumatol. 28, 1266\u20131270 (2001).","journal-title":"J. Rheumatol."},{"key":"57_CR114","first-page":"945","volume":"29","author":"MM Amoli","year":"2002","unstructured":"Amoli, M. M. et al. Henoch-Schonlein purpura and cutaneous leukocytoclastic angiitis exhibit different HLA-DRB1 associations. J. Rheumatol. 29, 945\u2013947 (2002).","journal-title":"J. Rheumatol."},{"key":"57_CR115","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/art.38979","volume":"67","author":"R L\u00f3pez-Mej\u00edas","year":"2015","unstructured":"L\u00f3pez-Mej\u00edas, R. et al. Brief Report: association of HLA\u2013DRB1*01 With IgA Vasculitis (Henoch-Sch\u00f6nlein). Arthritis Rheumatol. 67, 823\u2013827 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"57_CR116","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1365-2370.1997.d01-112.x","volume":"24","author":"A Amoroso","year":"1997","unstructured":"Amoroso, A. et al. Immunogenetics of Henoch-Schoenlein disease. Eur. J. Immunogenet. 24, 323\u2013333 (1997).","journal-title":"Eur. J. Immunogenet."},{"key":"57_CR117","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ng.3496","volume":"48","author":"C Sun","year":"2016","unstructured":"Sun, C. et al. High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry. Nat. Genet. 48, 323\u2013330 (2016).","journal-title":"Nat. Genet."},{"key":"57_CR118","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1086\/342290","volume":"71","author":"RR Graham","year":"2002","unstructured":"Graham, R. R. et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am. J. Hum. Genet. 71, 543\u2013553 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"57_CR119","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1681\/ASN.2016121331","volume":"28","author":"R Xu","year":"2017","unstructured":"Xu, R. et al. Association analysis of the MHC in lupus nephritis. J. Am. Soc. Nephrol. 28, 3383\u20133394 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR120","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/art.1780331012","volume":"33","author":"Z Fronek","year":"1990","unstructured":"Fronek, Z. et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum. 33, 1542\u20131553 (1990).","journal-title":"Arthritis Rheum."},{"key":"57_CR121","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1191\/0961203302lu158oa","volume":"11","author":"HM Bastian","year":"2002","unstructured":"Bastian, H. M. et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 11, 152\u2013160 (2002).","journal-title":"Lupus"},{"key":"57_CR122","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/rheumatology\/kel347","volume":"46","author":"HM Bastian","year":"2007","unstructured":"Bastian, H. M. et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. Rheumatology 46, 683\u2013689 (2007).","journal-title":"Rheumatology"},{"key":"57_CR123","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0198-8859(03)00017-X","volume":"64","author":"M Marchini","year":"2003","unstructured":"Marchini, M. et al. HLA class II antigens associated with lupus nephritis in Italian SLE patients. Hum. Immunol. 64, 462\u2013468 (2003).","journal-title":"Hum. Immunol."},{"key":"57_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13356-6","volume":"7","author":"S Wunnenburger","year":"2017","unstructured":"Wunnenburger, S. et al. Associations between genetic risk variants for kidney diseases and kidney disease etiology. Sci. Rep. 7, 13944 (2017).","journal-title":"Sci. Rep."},{"key":"57_CR125","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1681\/ASN.2013050446","volume":"25","author":"SA Chung","year":"2014","unstructured":"Chung, S. A. et al. Lupus nephritis susceptibility loci in women with systemic lupus erythematosus. J. Am. Soc. Nephrol. 25, 2859\u20132870 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR126","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/1756-185X.12528","volume":"18","author":"Z Niu","year":"2015","unstructured":"Niu, Z., Zhang, P. & Tong, Y. Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis. Int. J. Rheum. Dis. 18, 17\u201328 (2015).","journal-title":"Int. J. Rheum. Dis."},{"key":"57_CR127","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.4049\/jimmunol.1501073","volume":"195","author":"VR Chowdhary","year":"2015","unstructured":"Chowdhary, V. R. et al. A central role for HLA-DR3 in anti-Smith antibody responses and glomerulonephritis in a transgenic mouse model of spontaneous lupus. J.\u00a0Immunol. 195, 4660\u20134667 (2015).","journal-title":"J. Immunol."},{"key":"57_CR128","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/BF02231577","volume":"12","author":"S Janwityanuchit","year":"1993","unstructured":"Janwityanuchit, S., Verasertniyom, O., Vanichapuntu, M. & Vatanasuk, M. Anti-Sm: its predictive value in systemic lupus erythematosus. Clin. Rheumatol. 12, 350\u2013353 (1993).","journal-title":"Clin. Rheumatol."},{"key":"57_CR129","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1167\/iovs.02-0376","volume":"44","author":"RD Levinson","year":"2003","unstructured":"Levinson, R. D. et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest. Ophthal. Vis. Sci. 44, 653\u2013657 (2003).","journal-title":"Invest. Ophthal. Vis. Sci."},{"key":"57_CR130","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/bjo.2010.187955","volume":"95","author":"F Mackensen","year":"2011","unstructured":"Mackensen, F. et al. HLA-DRB1 0102 is associated with TINU syndrome and bilateral, sudden-onset anterior uveitis but not with interstitial nephritis alone. Br. J. Ophthalmol. 95, 971\u2013975 (2011).","journal-title":"Br. J. Ophthalmol."},{"key":"57_CR131","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/tan.12116","volume":"81","author":"J Perasaari","year":"2013","unstructured":"Perasaari, J. et al. HLA associations with tubulointerstitial nephritis with or without uveitis in Finnish pediatric population: a nation-wide study. Tissue Antigens 81, 435\u2013441 (2013).","journal-title":"Tissue Antigens"},{"key":"57_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1207-1","volume":"18","author":"V Matzaraki","year":"2017","unstructured":"Matzaraki, V., Kumar, V., Wijmenga, C. & Zhernakova, A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol. 18, 76 (2017).","journal-title":"Genome Biol."},{"key":"57_CR133","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1084\/jem.134.3.7","volume":"134","author":"CB Wilson","year":"1971","unstructured":"Wilson, C. B. & Dixon, F. J. Quantitation of acute and chronic serum sickness in the rabbit. J. Exp. Med. 134, 7\u201318 (1971).","journal-title":"J. Exp. Med."},{"key":"57_CR134","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1399-0039.1998.tb02276.x","volume":"52","author":"RW Vaughan","year":"1998","unstructured":"Vaughan, R. W., Zurowska, A., Moszkowska, G., Kondeatis, E. & Clark, A. G. HLA-DRB and -DQB1 alleles in Polish patients with hepatitis B associated membranous nephropathy. Tissue Antigens 52, 130\u2013134 (1998).","journal-title":"Tissue Antigens"},{"key":"57_CR135","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1046\/j.1523-1755.2002.00287.x","volume":"61","author":"R Bhimma","year":"2002","unstructured":"Bhimma, R., Hammond, M. G., Coovadia, H. M., Adhikari, M. & Connolly, C. A. HLA class I and II in black children with hepatitis B virus-associated membranous nephropathy. Kidney Int. 61, 1510\u20131515 (2002).","journal-title":"Kidney Int."},{"key":"57_CR136","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00467-002-0940-0","volume":"17","author":"R Bhimma","year":"2002","unstructured":"Bhimma, R. et al. HLA associations with HBV carriage and proteinuria. Pediatr. Nephrol. 17, 724\u2013729 (2002).","journal-title":"Pediatr. Nephrol."},{"key":"57_CR137","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1399-0039.2003.00141.x","volume":"62","author":"MH Park","year":"2003","unstructured":"Park, M. H. et al. Two subtypes of hepatitis B virus-associated glomerulonephritis are associated with different HLA-DR2 alleles in Koreans. Tissue Antigens 62, 505\u2013511 (2003).","journal-title":"Tissue Antigens"},{"key":"57_CR138","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000183599","volume":"41","author":"M Adhikari","year":"1985","unstructured":"Adhikari, M., Coovadia, H. M. & Hammond, M. G. Associations between HLA antigens and nephrotic syndrome in African and Indian children in South Africa. Nephron 41, 289\u2013292 (1985).","journal-title":"Nephron"},{"key":"57_CR139","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1034\/j.1399-0039.2002.590106.x","volume":"59","author":"SJ Hwang","year":"2002","unstructured":"Hwang, S. J. et al. Genetic predispositions for the presence of cryoglobulinemia and serum autoantibodies in Chinese patients with chronic hepatitis C. Tissue Antigens 59, 31\u201337 (2002).","journal-title":"Tissue Antigens"},{"key":"57_CR140","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/gene.2014.41","volume":"15","author":"AL Zignego","year":"2014","unstructured":"Zignego, A. L. et al. Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis. Genes Immun. 15, 500\u2013505 (2014).","journal-title":"Genes Immun."},{"key":"57_CR141","first-page":"1184","volume":"301","author":"T Sasazuki","year":"1979","unstructured":"Sasazuki, T., Hayase, R., Iwamoto, I. & Tsuchida, H. HLA and acute poststreptococcal glomerulonephritis. N. Eng. J. Med. 301, 1184\u20131185 (1979).","journal-title":"N. Eng. J. Med."},{"key":"57_CR142","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00467-006-0324-y","volume":"22","author":"A Bakr","year":"2007","unstructured":"Bakr, A., Mahmoud, L. A., Al-Chenawi, F. & Salah, A. HLA-DRB1* alleles in Egyptian children with post-streptococcal acute glomerulonephritis. Pediatr. Nephrol. 22, 376\u2013379 (2007).","journal-title":"Pediatr. Nephrol."},{"key":"57_CR143","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1651-2227.1996.tb14185.x","volume":"85","author":"K Mori","year":"1996","unstructured":"Mori, K., Sasazuki, T., Kimura, A. & Ito, Y. HLA-DP antigens and post-streptococcal acute glomerulonephritis. Acta Paediatr. 85, 916\u2013918 (1996).","journal-title":"Acta Paediatr."},{"key":"57_CR144","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035838","volume":"7","author":"D Payen","year":"2012","unstructured":"Payen, D. et al. A multicentre study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and HLA genotype. PLOS One 7, e35838 (2012).","journal-title":"PLOS One"},{"key":"57_CR145","first-page":"71","volume":"14","author":"CA Alfiler","year":"1980","unstructured":"Alfiler, C. A., Roy, L. P., Doran, T., Sheldon, A. & Bashir, H. HLA-DRw7 and steroid-responsive nephrotic syndrome of childhood. Clin. Nephrol. 14, 71\u201374 (1980).","journal-title":"Clin. Nephrol."},{"key":"57_CR146","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S0140-6736(80)90223-8","volume":"2","author":"A de Mouzon-Cambon","year":"1980","unstructured":"de Mouzon-Cambon, A., Ohayon, E., Bouissou, F. & Barthe, P. HLA-DR typing in children with glomerular diseases. Lancet 2, 868 (1980).","journal-title":"Lancet"},{"key":"57_CR147","first-page":"366","volume":"306","author":"A Nunez-Roldan","year":"1982","unstructured":"Nunez-Roldan, A., Villechenous, E., Fernandez-Andrade, C. & Martin-Govantes, J. Increased HLA-DR7 and decreased DR2 in steroid-responsive nephrotic syndrome. N. Eng. J.\u00a0Med. 306, 366\u2013367 (1982).","journal-title":"N. Eng. J. Med."},{"key":"57_CR148","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1399-0039.1994.tb02340.x","volume":"43","author":"M Konrad","year":"1994","unstructured":"Konrad, M. et al. HLA class II associations with idiopathic nephrotic syndrome in children. Tissue\u00a0Antigens 43, 275\u2013280 (1994).","journal-title":"Tissue Antigens"},{"key":"57_CR149","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1042\/cs0780391","volume":"78","author":"AG Clark","year":"1990","unstructured":"Clark, A. G. et al. Genes encoding the beta-chains of HLA-DR7 and HLA-DQw2 define major susceptibility determinants for idiopathic nephrotic syndrome. Clin.\u00a0Sci. 78, 391\u2013397 (1990).","journal-title":"Clin. Sci."},{"key":"57_CR150","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1681\/ASN.2014030247","volume":"26","author":"RA Gbadegesin","year":"2015","unstructured":"Gbadegesin, R. A. et al. HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome. J. Am. Soc. Nephrol. 26, 1701\u20131710 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"57_CR151","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00467-016-3456-8","volume":"32","author":"AM Karp","year":"2017","unstructured":"Karp, A. M. & Gbadegesin, R. A. Genetics of childhood steroid-sensitive nephrotic syndrome. Pediatr. Nephrol. 32, 1481\u20131488 (2017).","journal-title":"Pediatr. Nephrol."},{"key":"57_CR152","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.4049\/jimmunol.1103458","volume":"89","author":"G Fu","year":"2012","unstructured":"Fu, G., Chen, Y., Schuman, J., Wang, D. & Wen, R. Phospholipase C\u03b32 plays a role in TCR signal transduction and T cell selection. J. Immunol. 89, 2326\u20132332 (2012).","journal-title":"J. Immunol."},{"key":"57_CR153","doi-asserted-by":"publisher","first-page":"5660","DOI":"10.1073\/pnas.89.12.5660","volume":"89","author":"KM Coggeshall","year":"1992","unstructured":"Coggeshall, K. M., McHugh, J. C. & Altman, A. Predominant expression and activation-induced tyrosine phosphorylation of phospholipase C\u03b32 in B lymphocytes. Proc. Natl Acad. Sci. USA 89, 5660\u20135664 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"57_CR154","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1074-7613(00)00005-4","volume":"13","author":"D Wang","year":"2000","unstructured":"Wang, D. et al. Phospholipase C\u03b32 is essential in the functions of B cell and several Fc receptors. Immunity 13, 25\u201335 (2000).","journal-title":"Immunity"},{"key":"57_CR155","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ajhg.2012.08.006","volume":"91","author":"Q Zhou","year":"2012","unstructured":"Zhou, Q. et al. A hypermorphic missense mutation in PLCG2, encoding phospholipase C\u03b32, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am. J. Hum. Genet. 91, 713\u2013720 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"57_CR156","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1102140","volume":"366","author":"MJ Ombrello","year":"2012","unstructured":"Ombrello, M. J. et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N. Engl. J. Med. 366, 330\u2013338 (2012).","journal-title":"N. Engl. J. Med."},{"key":"57_CR157","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1590\/S0100-879X1998000400010","volume":"31","author":"EA Donadi","year":"1998","unstructured":"Donadi, E. A., Voltarelli, J. C., Paula-Santos, C. M., Kimachi, T. & Ferraz, A. S. Association of Alport\u2019s syndrome with HLA-DR2 antigen in a group of unrelated patients. Braz. J. Med. Biol. Res. 31, 533\u2013537 (1998).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"57_CR158","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2370.2004.00460.x","volume":"31","author":"S Barocci","year":"2004","unstructured":"Barocci, S. et al. Alport syndrome: HLA association and kidney graft outcome. Eur. J. Immunogenet. 31, 115\u2013119 (2004).","journal-title":"Eur. J. Immunogenet."},{"key":"57_CR159","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/BF01236275","volume":"17","author":"J Jervell","year":"1979","unstructured":"Jervell, J. & Solheim, B. HLA-antigens in long standing insulin dependent diabetics with terminal nephropathy and retinopathy with and without loss of vision. Diabetologia 17, 391 (1979).","journal-title":"Diabetologia"},{"key":"57_CR160","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF00253492","volume":"27","author":"C Walton","year":"1984","unstructured":"Walton, C. et al. HLA antigens and risk factors for nephropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 27, 3\u20137 (1984).","journal-title":"Diabetologia"},{"key":"57_CR161","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2337\/db07-0826","volume":"57","author":"SK Cordovado","year":"2008","unstructured":"Cordovado, S. K. et al. Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study. Diabetes 57, 518\u2013522 (2008).","journal-title":"Diabetes"},{"key":"57_CR162","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.humimm.2013.01.013","volume":"74","author":"EM Lipner","year":"2013","unstructured":"Lipner, E. M. et al. HLA class I and II alleles are associated with microvascular complications of type 1 diabetes. Hum. Immunol. 74, 538\u2013544 (2013).","journal-title":"Hum. Immunol."},{"key":"57_CR163","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai8708","volume":"9","author":"JH Karnes","year":"2017","unstructured":"Karnes, J. H. et al. Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants. Sci. Transl Med. 9, eaai8708 (2017).","journal-title":"Sci. Transl Med."},{"key":"57_CR164","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12882-016-0252-4","volume":"17","author":"D Razanskaite-Virbickiene","year":"2016","unstructured":"Razanskaite-Virbickiene, D., Danyte, E. & Zalinkevicius, R. HLA-DRB1*03 as a risk factor for microalbuminuria in same duration of type 1 diabetes: a case control study. BMC Nephrol. 17, 38 (2016).","journal-title":"BMC Nephrol."},{"key":"57_CR165","first-page":"461","volume":"83","author":"GF Watts","year":"1992","unstructured":"Watts, G. F., Taub, N., Gant, V., Wilson, I. & Shaw, K. M. The immunogenetics of early nephropathy in insulin-dependent diabetes mellitus: association between the HLAA2 antigen and albuminuria. Q. J. Med. 83, 461\u2013471 (1992).","journal-title":"Q. J. Med."},{"key":"57_CR166","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000070747","volume":"23","author":"R Dyck","year":"2003","unstructured":"Dyck, R., Bohm, C. & Klomp, H. Increased frequency of HLA A2\/DR4 and A2\/DR8 haplotypes in young Saskatchewan Aboriginal people with diabetic end-stage renal disease. Am. J. Nephrol. 23, 178\u2013185 (2003).","journal-title":"Am. J. Nephrol."},{"key":"57_CR167","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0198-8859(00)00174-9","volume":"61","author":"E Perez-Luque","year":"2000","unstructured":"Perez-Luque, E. et al. Contribution of HLA class II genes to end stage renal disease in mexican patients with type 2 diabetes mellitus. Hum. Immunol. 61, 1031\u20131038 (2000).","journal-title":"Hum. Immunol."},{"key":"57_CR168","doi-asserted-by":"publisher","first-page":"452537","DOI":"10.1155\/2013\/452537","volume":"2013","author":"ZJ Ma","year":"2013","unstructured":"Ma, Z. J., Sun, P., Guo, G., Zhang, R. & Chen, L. M. Association of the HLA-DQA1 and HLA-DQB1 alleles\u00a0in type 2 diabetes mellitus and diabetic nephropathy in the Han ethnicity of China. J. Diabetes Res. 2013, 452537 (2013).","journal-title":"J. Diabetes Res."},{"key":"57_CR169","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1007\/s00125-006-0412-3","volume":"49","author":"E Lindholm","year":"2006","unstructured":"Lindholm, E. et al. The \u2212374 T\/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients. Diabetologia 49, 2745\u20132755 (2006).","journal-title":"Diabetologia"},{"key":"57_CR170","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-010611-134701","volume":"52","author":"M Bharadwaj","year":"2012","unstructured":"Bharadwaj, M. et al. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex. Annu. Rev. Pharmacol. Toxicol. 52, 401\u2013431 (2012).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"57_CR171","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/ni.3679","volume":"18","author":"AN Keller","year":"2017","unstructured":"Keller, A. N. et al. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells. Nat. Immunol. 18, 402\u2013411 (2017).","journal-title":"Nat. Immunol."},{"key":"57_CR172","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ni.3523","volume":"17","author":"JH Kim","year":"2016","unstructured":"Kim, J. H. et al. CD1a on Langerhans cells controls inflammatory skin disease. Nat. Immunol. 17, 1159\u20131166 (2016).","journal-title":"Nat. Immunol."},{"key":"57_CR173","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1126\/scitranslmed.aad6833","volume":"8","author":"R Jarrett","year":"2016","unstructured":"Jarrett, R. et al. Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase. Sci. Transl Med. 8, 325 (2016).","journal-title":"Sci. Transl Med."},{"key":"57_CR174","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung, S. I. et al. HLAB*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc. Natl Acad. Sci. USA 102, 4134\u20134139 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"57_CR175","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jid.2016.02.808","volume":"136","author":"CY Ng","year":"2016","unstructured":"Ng, C. Y. et al. Impact of the HLA-B(*)58:01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions. J. Invest. Dermatol. 136, 1373\u20131381 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"57_CR176","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/cea.12184","volume":"43","author":"J Yun","year":"2013","unstructured":"Yun, J. et al. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response. Clin. Exp. Allergy 43, 1246\u20131255 (2013).","journal-title":"Clin. Exp. Allergy"},{"key":"57_CR177","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1136\/annrheumdis-2014-205577","volume":"74","author":"WH Chung","year":"2015","unstructured":"Chung, W. H. et al. Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin. Ann.\u00a0Rheum. Dis. 74, 2157\u20132164 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"57_CR178","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1056\/NEJM196812052792302","volume":"279","author":"DS Baldwin","year":"1968","unstructured":"Baldwin, D. S., Levine, B. B., McCluskey, R. T. & Gallo, G. R. Renal failure and interstitial nephritis due to penicillin and methicillin. N. Engl. J. Med. 279, 1245\u20131252 (1968).","journal-title":"N. Engl. J. Med."},{"key":"57_CR179","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1159\/000169183","volume":"17","author":"J Karpinski","year":"1997","unstructured":"Karpinski, J., Jothy, S., Radoux, V., Levy, M. & Baran, D. D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature. Am. J. Nephrol. 17, 528\u2013532 (1997).","journal-title":"Am. J. Nephrol."},{"key":"57_CR180","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/ard.52.4.300","volume":"52","author":"LI Sakkas","year":"1993","unstructured":"Sakkas, L. I., Chikanza, I. C., Vaughan, R. W., Welsh, K. I. & Panayi, G. S. Gold induced nephropathy in rheumatoid arthritis and HLA class II genes. Ann.\u00a0Rheum. Dis. 52, 300\u2013301 (1993).","journal-title":"Ann. Rheum. Dis."},{"key":"57_CR181","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1056\/NEJM198008073030602","volume":"303","author":"PH Wooley","year":"1980","unstructured":"Wooley, P. H. et al. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N. Engl. J. Med. 303, 300\u2013302 (1980).","journal-title":"N. Engl. J. Med."},{"key":"57_CR182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111403","volume":"9","author":"NM Hamdi","year":"2014","unstructured":"Hamdi, N. M., Al-Hababi, F. H. & Eid, A. E. HLA class I and class II associations with ESRD in Saudi Arabian population. PLOS One 9, e111403 (2014).","journal-title":"PLOS One"},{"key":"57_CR183","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3109\/0886022X.2014.937672","volume":"36","author":"YM Mosaad","year":"2014","unstructured":"Mosaad, Y. M. et al. Association between human leukocyte antigens (HLAA, B, and -DR) and end-stage renal disease in Kuwaiti patients awaiting transplantation. Ren. Fail. 36, 1317\u20131321 (2014).","journal-title":"Ren. Fail."},{"key":"57_CR184","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12882-015-0165-7","volume":"16","author":"CS Dai","year":"2015","unstructured":"Dai, C. S. et al. Association between human leucocyte antigen subtypes and risk of end stage renal disease in Taiwanese: a retrospective study. BMC Nephrol. 16, 177 (2015).","journal-title":"BMC Nephrol."},{"key":"57_CR185","doi-asserted-by":"publisher","first-page":"D423","DOI":"10.1093\/nar\/gku1161","volume":"43","author":"J Robinson","year":"2015","unstructured":"Robinson, J. et al. The IPD and IMGT\/HLA database: allele variant databases. Nucleic Acids Res. 43, D423\u2013D431 (2015).","journal-title":"Nucleic Acids Res."},{"key":"57_CR186","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.coi.2016.03.007","volume":"40","author":"AW Purcell","year":"2016","unstructured":"Purcell, A. W., Croft, N. P. & Tscharke, D. C. Immunology by numbers: quantitation of antigen presentation completes the quantitative milieu of systems immunology! Curr. Opin. Immunol. 40, 88\u201395 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"57_CR187","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.immuni.2009.09.025","volume":"31","author":"WA Macdonald","year":"2009","unstructured":"Macdonald, W. A. et al. T cell allorecognition via molecular mimicry. Immunity 31, 897\u2013908 (2009).","journal-title":"Immunity"},{"key":"57_CR188","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.immuni.2012.07.013","volume":"37","author":"SE Broughton","year":"2012","unstructured":"Broughton, S. E. et al. Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease. Immunity 37, 611\u2013621 (2012).","journal-title":"Immunity"},{"key":"57_CR189","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-1-4684-8953-8_23","volume":"252","author":"CL Hall","year":"1989","unstructured":"Hall, C. L. The natural course of gold and penicillamine nephropathy: a longterm study of 54 patients. Adv.\u00a0Exp. Med. Biol. 252, 247\u2013256 (1989).","journal-title":"Adv. Exp. Med. Biol."},{"key":"57_CR190","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1744-313X.1995.tb00228.x","volume":"22","author":"RW Vaughan","year":"1995","unstructured":"Vaughan, R. W. et al. An analysis of HLA class II gene polymorphism in British and Greek idiopathic membranous nephropathy patients. Eur. J. Immunogenet. 22, 179\u2013186 (1995).","journal-title":"Eur. J. Immunogenet."},{"key":"57_CR191","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1399-0039.1997.tb02855.x","volume":"50","author":"D Chevrier","year":"1997","unstructured":"Chevrier, D. et al. Idiopathic and secondary membranous nephropathy and polymorphism at TAP1 and HLA-DMA loci. Tissue Antigens 50, 164\u2013169 (1997).","journal-title":"Tissue Antigens"},{"key":"57_CR192","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-13-33","volume":"13","author":"Y Jiyun","year":"2012","unstructured":"Jiyun, Y. et al. The genetic variants at the HLA-DRB1 gene are associated with primary IgA nephropathy in Han Chinese. BMC Med. Genet. 13, 33 (2012).","journal-title":"BMC Med. Genet."},{"key":"57_CR193","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1093\/ndt\/gfh355","volume":"19","author":"U Persson","year":"2004","unstructured":"Persson, U. et al. Patients with Goodpasture\u2019s disease have two normal COL4A3 alleles encoding the NC1 domain of the type IV collagen alpha 3 chain. Nephrol. Dial. Transplant. 19, 2030\u20132035 (2004).","journal-title":"Nephrol. Dial. Transplant."},{"key":"57_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/srep38189","volume":"6","author":"M Thiri","year":"2016","unstructured":"Thiri, M. et al. High-density association mapping and interaction analysis of PLA2R1 and HLA regions with idiopathic membranous nephropathy in Japanese. Sci. Rep. 6, 38189 (2016).","journal-title":"Sci. Rep."},{"key":"57_CR195","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/ki.1991.121","volume":"39","author":"PK Li","year":"1991","unstructured":"Li, P. K. et al. The DQw7 allele at the HLA-DQB locus is associated with susceptibility to IgA nephropathy in Caucasians. Kidney Int. 39, 961\u2013965 (1991).","journal-title":"Kidney Int."},{"key":"57_CR196","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ki.1990.75","volume":"37","author":"RH Moore","year":"1990","unstructured":"Moore, R. H. et al. HLA DQ region gene polymorphism associated with primary IgA nephropathy. Kidney Int. 37, 991\u2013995 (1990).","journal-title":"Kidney Int."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-018-0057-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-018-0057-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-018-0057-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T23:13:21Z","timestamp":1650410001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-018-0057-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":196,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1038\/s41581-018-0057-8","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,11]]},"assertion":[{"value":"11 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}